Have a look at the latest new products from Cell Signaling Technology.
The TubeMarker™ allows printing text, linear barcodes, 2D codes and graphics directly onto the surface of plastic laboratory tubes using patent pending Thermal Pixel Printing technology.
The latest innovation in sonication technology is the Q800R2 Sonicator from Qsonica.
Target enrichment, coupled with next generation sequencing (NGS), enables high throughput, deep sequencing of genomic regions of interest. NEBNext Direct is a novel, hybridization-based capture method offering significant advantages over traditional in-solution hybridization and multiplex PCR protocols.
The Ultra II DNA Library Prep Kit for Illumina meets the challenge of constructing high quality libraries from ever-decreasing input quantities. The reagents for each step in the library preparation workflow have been reformulated to enable high yield preparation of high quality libraries from 500 picograms to 1 microgram of input DNA........
It's time to transform your DNA purification experience. NEB’s Monarch Nucleic Acid Purification Kits are optimized for maximum performance and minimal environmental impact. Our unique thin-walled column design uses less plastic, prevents buffer retention, eliminates the risk of carryover contamination, and enables elution in smaller volumes. The result: high performing DNA purification for your downstream applications.
Struggling with DNA isolation from hard-to-lyse samples?
An app for precise quantification of mammalian DNA is available on DropSense16. Trinean's proprietary cDrop software is used to analyse the UV/VIS spectral of the sample to isolate the profile of the desired analyte (here DNA) from interfering contaminants. The specific DNA profile is then used to determine the correct DNA concentration. In this note we describe how to use this application and how to interpret its results.
Our new phospho-Tau (Ser416) mAb is the only available monoclonal antibody that can detect endogenous phospho-Tau by WB, IP and IHC.
ROS1 is an orphan receptor tyrosine kinase. Oncogenic fusions of ROS1 have been identified by research studies in glioblastoma(1), cholangiocarcinoma, ovarian cancer, and non-small cell lung cancer.
CRISPR/Cas9 and Targeted Genome Editing: A New Era in Molecular Biology.